Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists
CLVR

CLVR - Clever Leaves Holdings Inc. Stock Price, Fair Value and News

2.84USD-0.01 (-0.35%)Market Closed

Market Summary

CLVR
USD2.84-0.01
Market Closed
-0.35%

CLVR Stock Price

View Fullscreen

CLVR RSI Chart

CLVR Valuation

Market Cap

5.0M

Price/Earnings (Trailing)

-0.28

Price/Sales (Trailing)

0.29

EV/EBITDA

0.1

Price/Free Cashflow

-0.43

CLVR Price/Sales (Trailing)

CLVR Profitability

Operating Margin

22.66%

EBT Margin

-113.27%

Return on Equity

-73.91%

Return on Assets

-57.29%

Free Cashflow Yield

-231.54%

CLVR Fundamentals

CLVR Revenue

Revenue (TTM)

17.4M

Rev. Growth (Yr)

5.36%

Rev. Growth (Qtr)

21.41%

CLVR Earnings

Earnings (TTM)

-17.9M

Earnings Growth (Yr)

82.35%

Earnings Growth (Qtr)

1.03%

Breaking Down CLVR Revenue

Last 7 days

23.5%

Last 30 days

-12.6%

Last 90 days

-37.3%

Trailing 12 Months

-59.5%

How does CLVR drawdown profile look like?

CLVR Financial Health

Current Ratio

2.4

Debt/Equity

0.24

Debt/Cashflow

-1.96

CLVR Investor Care

Shares Dilution (1Y)

19.63%

Diluted EPS (TTM)

-11.36

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202315.3M16.2M17.2M17.4M
202216.9M17.4M16.2M16.4M
202126.5M28.2M28.3M15.4M
202012.3M16.9M21.4M25.9M
20190007.8M

Tracking the Latest Insider Buys and Sells of Clever Leaves Holdings Inc.

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Mar 08, 2024
hague henry r iii
sold
-562
3.3108
-170
chief financial officer
Feb 27, 2024
hague henry r iii
sold
-1,623
3.95
-411
chief financial officer
Jan 19, 2024
wilches julian
sold
-377
2.884
-131
chief regulatory officer
Jan 19, 2024
fajardo andres
sold
-4,501
2.884
-1,561
chief executive officer
Dec 20, 2023
fajardo andres
sold
-360
2.0367
-177
chief executive officer
Dec 20, 2023
wilches julian
sold
-274
2.0367
-135
chief regulatory officer
Jul 18, 2023
hague henry r iii
sold
-335
0.2152
-1,560
chief financial officer
Jul 18, 2023
wilches julian
sold
-174
0.2152
-813
chief regulatory officer

1–10 of 50

Which funds bought or sold CLVR recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
May 15, 2024
MORGAN STANLEY
unchanged
-
122
214
-%
May 15, 2024
BANK OF AMERICA CORP /DE/
new
-
4.00
4.00
-%
May 15, 2024
Royal Bank of Canada
added
573
1,000
1,000
-%
May 15, 2024
Nemes Rush Group LLC
unchanged
-
88.00
156
-%
May 15, 2024
Walleye Capital LLC
unchanged
-
10,158
18,220
-%
May 15, 2024
TWO SIGMA SECURITIES, LLC
sold off
-100
-438
-
-%
May 15, 2024
GTS SECURITIES LLC
new
-
440
440
-%
May 15, 2024
Tower Research Capital LLC (TRC)
reduced
-17.15
4,219
8,776
-%
May 15, 2024
Penserra Capital Management LLC
unchanged
-
14,000
24,000
-%
May 15, 2024
Davidson Kempner Capital Management LP
unchanged
-
7,344
11,313
-%

1–10 of 28

Are Funds Buying or Selling CLVR?

Are funds buying CLVR calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own CLVR
No. of Funds

Unveiling Clever Leaves Holdings Inc.'s Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
May 21, 2024
bcm investimentos fundo de investimento multimercado credito privado investimento no exterior
18.36%
322,236
SC 13D/A
May 15, 2024
bcm investimentos fundo de investimento multimercado credito privado investimento no exterior
8.5%
149,271
SC 13D
Jan 23, 2024
farallon capital management llc
0.0%
0
SC 13G/A
May 23, 2023
detwiler kyle
4.9%
2,224,241
SC 13D/A
Apr 03, 2023
schultze special purpose acquisition sponsor, llc
5.0%
2,248,844
SC 13D/A
Feb 09, 2023
farallon capital management llc
6.1%
2,668,551
SC 13G/A
Feb 14, 2022
farallon capital management llc
9.99%
2,719,118
SC 13G/A
Feb 14, 2022
etf managers group, llc
3.54%
949,286
SC 13G/A
Feb 07, 2022
schultze special purpose acquisition sponsor, llc
8.4%
2,248,844
SC 13D/A

Recent SEC filings of Clever Leaves Holdings Inc.

View All Filings
Date Filed Form Type Document
May 21, 2024
SC 13D/A
13D - Major Acquisition
May 21, 2024
3
Insider Trading
May 16, 2024
15-12G
15-12G
May 15, 2024
SC 13D
13D - Major Acquisition
May 08, 2024
EFFECT
EFFECT
May 06, 2024
S-8 POS
Employee Benefits Plan
May 06, 2024
S-8 POS
Employee Benefits Plan
May 06, 2024
S-8 POS
Employee Benefits Plan
May 06, 2024
POS AM
POS AM
May 06, 2024
25
25

Peers (Alternatives to Clever Leaves Holdings Inc.)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
360.9B
85.6B
3.13% -5.57%
9.38
4.21
5.68% 202.39%
323.6B
61.4B
-1.87% 20.17%
140.33
5.27
6.11% -82.30%
177.5B
29.5B
9.90% 45.35%
47.17
6.01
12.76% -52.47%
163.9B
35.0B
4.59% -19.77%
141.08
4.68
-26.40% -92.03%
87.2B
27.4B
8.77% -8.77%
179.95
3.18
1.51% -91.32%
19.4B
16.0B
0.35% 113.33%
-39.24
1.21
7.23% 71.10%
MID-CAP
4.0B
1.7B
-5.15% -21.49%
9.18
2.31
54.01% 364.56%
3.7B
4.6B
-1.29% -17.33%
-486.5
0.82
-0.06% 94.55%
2.7B
9.0B
17.59% -11.67%
-5.98
0.3
10.01% -27.45%
1.9B
676.2M
-4.35% -30.01%
12.23
2.8
30.38% 66.04%
SMALL-CAP
1.5B
743.2M
6.21% 3.87%
-4.13
1.96
24.65% 80.36%
21.0M
1.3M
-11.22% -53.81%
-2.83
16.12
-98.14% -104.71%
15.8M
89.6M
-5.10% -27.34%
-1.11
0.19
287.27% -129.41%
9.8M
21.5M
297.22% -51.36%
-1.26
0.46
66.16% 61.84%
322.9K
115.7M
-61.54% -97.23%
0
0
-2.22% -352.48%

Clever Leaves Holdings Inc. News

Latest updates
Benzinga2 months ago
Green Market Report2 months ago

Clever Leaves Holdings Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q4
Revenue21.4%4,638,0003,820,0004,981,0003,978,0004,402,0002,867,0004,100,0005,041,0004,194,0004,031,0003,672,0003,477,00017,121,0003,917,0001,939,0002,914,000-
Gross Profit-117.8%-346,0001,942,0002,726,0002,234,000844,0001,299,0002,481,0002,593,000970,0001,931,0001,768,0002,140,0002,272,0002,073,000907,0002,161,000-
Operating Expenses-14.2%4,566,0005,319,0005,901,0006,364,0008,371,50025,623,0007,829,00012,312,00031,122,00011,615,00011,371,0009,908,0009,590,0006,784,0008,232,00011,335,000-
  S&GA Expenses-25.1%436,000582,000469,000549,000-178,000615,000728,000732,0001,879,000208,000241,000587,000285,000508,000603,0001,181,000-
  R&D Expenses-20.2%233,000292,000403,000212,000605,000343,000359,000412,000509,000454,000305,000278,000-----
EBITDA Margin11.7%-1.06-1.21-2.36-2.15-2.59-3.47-1.75-2.42-2.65-0.70-0.95-1.01-0.90-1.98-2.51-3.42-5.40
Interest Expenses-----65,000--375,000117,000--548,000-65,000----
Income Taxes------------------
Earnings Before Taxes30.6%-5,046,000-7,271,000-3,261,000-4,151,000-7,348,000-24,841,0001,856,000-13,761,000-22,994,0001,009,000-8,942,000-13,754,000-846,000-6,106,000-8,748,000-10,175,000-
EBT Margin11.7%-1.13-1.28-2.44-2.25-2.69-3.69-1.95-2.64-2.91-0.80-1.05-1.11-1.00-2.15-2.72-3.72-5.86
Net Income1.0%-5,085,000-5,138,000-3,595,000-4,081,000-28,816,000-20,163,000-1,046,000-16,140,000-24,000,000995,000-8,956,000-13,765,000-2,686,000-5,094,000-8,753,000-10,186,000-
Net Income Margin57.6%-1.03-2.42-3.49-3.53-4.03-3.79-2.31-2.84-2.97-0.86-1.08-1.15-1.03-1.85-2.34-3.20-5.05
Free Cashflow39.9%-1,387,000-2,309,000-1,731,000-6,112,000-4,547,000-5,640,000-8,599,000-11,586,000-9,370,000-10,328,000-10,972,000-12,843,000-4,061,000-3,586,000-9,103,000-8,876,000-
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42019Q4
Assets-17.3%31.0038.0043.0046.0052.0081.0010512711614115015916696.00
  Current Assets-22.3%14.0018.0018.0021.0026.0041.0044.0069.0060.0068.0077.0087.0096.0024.00
    Cash Equivalents5.5%7.006.005.006.0012.0018.0019.0045.0038.0046.0057.0069.0079.0013.00
  Inventory-41.8%4.008.007.008.008.0017.0017.0016.0015.0014.0013.0012.0010.005.00
  Net PPE-3.4%12.0013.0013.0013.0014.0029.0030.0030.0031.0030.0029.0027.0026.0024.00
  Goodwill----------19.0019.0019.0019.0020.00
Liabilities-13.1%7.008.009.009.0012.0012.0021.0045.0043.0053.0071.0074.0071.0046.00
  Current Liabilities-15.1%6.007.008.008.009.008.009.0027.0027.0033.0057.0031.0030.006.00
  Long Term Debt----------6.00-27.007.0027.00
Shareholder's Equity-18.4%24.0030.0034.0037.0040.0070.0085.0082.0073.0088.0079.0084.0095.0050.00
  Retained Earnings-2.6%-198-193-188-184-180-152-131-130-114-90.74-91.73-82.78-69.01-31.93
  Additional Paid-In Capital-0.2%22322322322222122221721318817817116716477.00
Accumulated Depreciation4.8%9.008.008.008.007.008.007.006.006.005.004.004.003.001.00
Shares Outstanding0.1%2.002.002.001.001.001.001.001.001.001.001.001.001.000.00
Float---12.00---36.00---132---
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q4
Cashflow From Operations29.9%-1,543-2,201-1,687-6,077-5,097-5,385-8,213-10,371-8,038-8,699-8,869-10,627-3,682-3,736-7,322-7,221-
  Share Based Compensation-361.5%-13652.00434468-2639581,1485003,3143,2643,3231,550747489-297416-
Cashflow From Investing-24.3%2,0562,717-44.00-35.00550-2552,112-1,215-1,332-1,629-2,103-2,216-379150-1,781-1,655-
Cashflow From Financing-121.3%-162760165-107-2503,886-19,03818,691883-585-1,0972,63377,2063,653-5,98716,966-
  Buy Backs---------------6,250--
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

CLVR Income Statement

2023-12-31
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]  
Revenue, net$ 17,417,000$ 16,410,000
Cost of sales(10,861,000)(9,193,000)
Gross profit6,556,0007,217,000
Expenses  
General and administrative17,993,00023,830,000
Sales and marketing2,036,0001,897,000
Research and development1,140,0001,719,000
Restructuring expenses06,449,000
Intangible asset impairment019,000,000
Depreciation and amortization981,0001,241,000
Total expenses22,150,00054,136,000
Loss from operations(15,594,000)(46,919,000)
Other Expense (Income), net  
Interest expense and amortization of debt issuance cost46,0002,672,000
Gain on remeasurement of warrant liability(113,000)(2,092,000)
Loss (Gain) on investments3,738,000(6,851,000)
Loss on debt extinguishment, net02,263,000
Foreign exchange loss433,000963,000
Other expense, net31,000220,000
Total other expense (income), net4,135,000(2,825,000)
Loss before income taxes and equity investment loss(19,729,000)(44,094,000)
Deferred income tax recovery0(6,650,000)
Income tax provision68,000296,000
Equity investment share of loss064,000
Loss from continuing operations(19,797,000)(37,804,000)
Gain/(loss) from discontinued operations1,898,000(28,361,000)
Net loss attributable to Clever Leaves Holdings Inc. common shareholders - basic(17,899,000)(66,165,000)
Net loss attributable to Clever Leaves Holdings Inc. common shareholders - diluted$ (17,899,000)$ (66,165,000)
Basic - continuing operations (in dollars per share)$ (12.63)$ (29.54)
Diluted - continuing operations (in dollars per share)(12.63)(29.54)
Basic - discontinued operations (in dollars per share)1.21(22.16)
Diluted - discontinued operations (in dollars per share)1.21(22.16)
Net loss per share - basic (in dollars per share)(11.42)(51.70)
Net loss per share - diluted (in dollars per share)$ (11.42)$ (51.70)
Weighted-average common shares outstanding - basic (in shares)1,567,6011,279,746
Weighted-average common shares outstanding - diluted (in shares)1,567,6011,279,746

CLVR Balance Sheet

2023-12-31
Consolidated Statements of Financial Position - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current:  
Cash and cash equivalents$ 6,831$ 12,449
Restricted cash70439
Accounts receivable, net9072,252
Prepaids, deposits and other receivables1,6492,708
Inventories, net4,4838,399
Total current assets13,94026,247
Investment – Cansativa05,679
Property, plant and equipment, net of accumulated depreciation of $8,793 and $7,120 for the years ended December 31, 2023 and 2022, respectively12,32113,963
Land held for sale1,5001,500
Intangible assets, net2,6533,354
Operating lease right-of-use assets, net8291,303
Other non-current assets052
Total Assets31,24352,098
Current:  
Accounts payable2,0632,299
Accrued expense and other current liabilities2,8444,238
Loans and borrowings, current portion498465
Warrant liability0113
Operating lease liabilities, current portion3861,239
Deferred revenue201,072
Total current liabilities5,8119,426
Loans and borrowings7201,065
Operating lease liabilities — long-term4831,087
Other long-term liabilities12112
Total Liabilities7,02611,690
Contingencies and commitments
Shareholders’ equity  
Preferred shares, without par value, unlimited shares authorized, nil shares issued and outstanding for each of December 31, 2023 and 202200
Common shares, without par value, unlimited shares authorized: 1,727,698 and 1,454,559 shares issued and outstanding as of December 31, 2023 and 2022, respectively00
Additional paid-in capital223,021221,313
Accumulated deficit(198,804)(180,905)
Total shareholders' equity24,21740,408
Total liabilities and shareholders' equity$ 31,243$ 52,098
CLVR
Clever Leaves Holdings Inc. operates in the botanical cannabinoid and nutraceutical industries. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment engages in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products internationally. The Non-Cannabinoid segment is engaged in formulating, manufacturing, marketing, selling, distributing, and commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. It also produces extracted products, including isolates, crude oil extracts, standardized extracts, and oral solutions, as well as tetrahydrocannabinol flower. The company was incorporated in 2017 and is based in Tocancipá, Colombia.
 CEO
 WEBSITEhttps://cleverleaves.com
 INDUSTRYPharmaceuticals
 EMPLOYEES400

Clever Leaves Holdings Inc. Frequently Asked Questions


What is the ticker symbol for Clever Leaves Holdings Inc.? What does CLVR stand for in stocks?

CLVR is the stock ticker symbol of Clever Leaves Holdings Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Clever Leaves Holdings Inc. (CLVR)?

As of Fri Jul 12 2024, market cap of Clever Leaves Holdings Inc. is 4.98 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CLVR stock?

You can check CLVR's fair value in chart for subscribers.

What is the fair value of CLVR stock?

You can check CLVR's fair value in chart for subscribers. The fair value of Clever Leaves Holdings Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Clever Leaves Holdings Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CLVR so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Clever Leaves Holdings Inc. a good stock to buy?

The fair value guage provides a quick view whether CLVR is over valued or under valued. Whether Clever Leaves Holdings Inc. is cheap or expensive depends on the assumptions which impact Clever Leaves Holdings Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CLVR.

What is Clever Leaves Holdings Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Jul 12 2024, CLVR's PE ratio (Price to Earnings) is -0.28 and Price to Sales (PS) ratio is 0.29. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CLVR PE ratio will change depending on the future growth rate expectations of investors.